Annual Forecast Weighs On Healthcare Name

Abbot Laboratories (ABT) announced better-than-expected fourth-quarter earnings results ahead of the open today. Boosted by the demand for Covid-19 test kits and its diagnostics products, the company reported profits of $1.32 per share, beating analyst estimates by 11 cents, as well as a revenue beat. However, ABT is down 1.9% to trade at $120.90 at last check, as the healthcare name also lowered its 2022 forecast due to the uncertainty of the pandemic.

Read more: Annual Forecast W...

Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Lilly's Pivotal Phase 3 Atopic Dermatitis Studies

Millions of people with atopic dermatitis cope with both seen and unseen burdens of the disease. Discover more about important new clinical trial results and how Lilly is helping to improve care and understanding of this disease here.

Read more: Majority of Patie...

Germany’s e-health transformation makes uneven progress

Germany’s e-health transformation makes uneven progress. This McKinsey & Company article summarizes the findings from the annual book "eHealth Monitor" that was published recently in the MWV Publishing House. Read more here.

Read more: Germany’s e-healt...

Qualio starts 2022 the right way at the G2 Spring Awards

The G2 Spring 2022 report is out! Congratulations Qualio for being awarded the #1 position for Medical QMS Implementation, Results, Momentum, and Usability! Read more here.

Read more: Qualio starts 202...

SAP.iO #Intrapreneurship program 2022 will kick off again today!

Launch new meaningful ventures inside of SAP by building and validating your product alongside real users, mentors, and customers.  Read more here.

Read more: SAP.iO #Intrapren...

How Quin’s decision to tackle diabetes distress helps diabetes patients stay in range

        By Teresa Murray, freelance writer & Giant Health Team writer When you hear Cyndi Williams of Quin talk about diabetes, you are struck not only by the depth of her knowledge, but also by how much she cares about…

Read more: How Quin’s decisi...

My Language Connection helped Medeuroent by translating Informed Consents and feedback questionnaires for their patients

  The project involved the translation of medical documents with over 10,000 words, high level proofreading, and the creation of Translation Memory and Glossary. Read more here.

Read more: My Language Conne...

Burgopak packaging designers awarded a triple win at the GDUSA 58th Annual awards

The GDUSA Annual Awards showcase the best in show of Marketing, Packaging and Graphic design from around the world.  Packaging designers at Burgopak are leading the way, taking home three awards at this years GDUSA 58th Annual awards in partnership with Stephen Gould and clients…

Read more: Burgopak packagin...

Webinar: No-Code for Coders: Empowering Developers to Turbocharge Project Delivery

The no-code movement is picking up pace. There’s a lot of talk about citizen development and its potential to speed up IT project delivery and innovation, reducing reliance on developers. But the benefits of no-code for coders can sometimes be…

Read more: Webinar: No-Code ...

McKinsey Open Innovation Forum: Quantum Computing

Quantum computing has seen several breakthroughs in recent times. Meet McKinsey experts and a guest from Aspen Quantum Computing in their upcoming webinar on 24 March 2022 at 15:00 CET Registration Link here.

Read more: McKinsey Open Inn...

We’re excited to be involved with Mediaplanet on the Supporting the NHS campaign

We supported the Supporting the NHS campaign that launched on the 14 th of March within the Guardian and online here.  Supporting the NHS looked at how we can relieve pressures on the NHS and how everyone plays a part…

Read more: We’re excited to ...

Check out Ayming latest Business Insight Note

Concern for #health of the individual,as well as the planet, is changing food & drink consumption. In Ayming latest Business Insight Note they studied the latest #food #revolution that is taking this industry by storm. Download free copy here.

Read more: Check out Ayming ...